Trial
NCT04890548
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Heart Failure
Intervention
AZD3427
Why stopped
Study start up timelines delayed into late autumn, and with COVID cases rising in the UK, the feasibility of successfully recruiting the study and ethical concerns about starting a study that AZ may not be able to complete.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-17